Drug
Flumatinib clinical trials
Includes 2 studies of Flumatinib mesylate.
- studies test it
- 11
- open now
- 3
- in phase 3
- 2
- first study started
- 2011
Keep track of what changes. Save the flumatinib studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
11 studies that test it; most in 2021 (4)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 3
- Phase 3
- 2
- Phase 4
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 5
Jiangsu Hansoh Pharmaceutical Co., Ltd. (5) · Shenzhen Second People's Hospital (2) · The First Affiliated Hospital of Soochow University (1) · Institute of Hematology & Blood Diseases Hospital, China (1) · Zhongda Hospital (1) · Jiangsu HengRui Medicine Co., Ltd. (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses flumatinib is read from its arms, and is right about nine times in ten.
Testing it · 11
- Study of HS-10382 Combination in Patients With Chronic Myeloid Leukemia (CML)Not yet recruitingPhase 1Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT06530810Written as HS-10382+Flumatinib
- A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic PhaseNot yet recruitingPhase 4Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT05367765Written as Flumatinib
- A Study of the Efficacy and Safety of Flumatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.RecruitingPhase 4Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT05353205Written as Flumatinib mesylate tablets (400mg)
- Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALLTerminatedPhase 4Institute of Hematology & Blood Diseases Hospital, ChinaNCT05071482Written as Flumatinib
- Study of Azacitidine，Venetoclax，and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP PatientsCompletedPhase 2The First Affiliated Hospital of Soochow UniversityNCT05433532Written as Flumatinib
- The Efficacy and Safety of Switching to Flumatinib Versus Dasatinib After Imatinib-related Low-grade Adverse Events in CML-CP PatientsStatus unknownPhase 4Shenzhen Second People's HospitalNCT04933526Written as Flumatinib
- Study of Efficacy and Safety of Flumatinib Combined With Chemotherapy in Ph Positive ALLStatus unknownPhase 3Zhongda HospitalNCT04375683Written as Flumatinib
- Flumatinib in CML-CP Patients With Ph+ Post Imatinib FailureStatus unknownPhase 4Shenzhen Second People's HospitalNCT04677439Written as Flumatinib
- The Study of the Efficacy and the Safety of Flumatinib vs Imatinib as First Line Treatment in Patients With CMLCompletedPhase 3Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT02204644Written as Flumatinib 600mg qd
- A Phase II Study to Evaluate the Efficacy and the Safety of Flumatinib in CML-AP or CML-BP PatientsStatus unknownPhase 2Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT02511340Written as Flumatinib mesylate tablet 600 mg qd
- A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous LeukemiaStatus unknownPhase 2Jiangsu HengRui Medicine Co., Ltd.NCT01503502Written as flumatinib
As the comparator · 1 — what is tested is compared with flumatinib
Codes
What other systems call flumatinib · ClinicalTrials.gg INT005734
- MeSH (NLM) C553360flumatinibConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) R4009Y24AIFLUMBATINIBConfirmed FDA, NLM, Wikidata
- Wikidata Q27287759flumatinibConfirmed FDA, NLM, Wikidata
- DrugBank DB11904One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C553360 | flumatinib | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | R4009Y24AI | FLUMBATINIB | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27287759 | flumatinib | Confirmed FDA, NLM, Wikidata |
| DrugBank | DB11904 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.